ID   B901L-CD80
AC   CVCL_A5AT
DR   Wikidata; Q107113429
RX   PubMed=11267941;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; 3236; EGFR; Simple; p.Glu746_Ala750del; Zygosity=Unspecified (from parent cell line).
CC   Transfected with: HGNC; 1700; CD80.
CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U098 ! B901L
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
RX   PubMed=11267941; DOI=10.1111/j.1349-7006.2001.tb01096.x;
RA   Takenoyama M., Yoshino I., Eifuku R., So T., Imahayashi S., Sugaya M.,
RA   Yasuda M., Inoue M., Ichiyoshi Y., Osaki T., Nagashima A., Nomoto K.,
RA   Yasumoto K.;
RT   "Successful induction of tumor-specific cytotoxic T lymphocytes from
RT   patients with non-small cell lung cancer using CD80-transfected
RT   autologous tumor cells.";
RL   Jpn. J. Cancer Res. 92:309-315(2001).
//